Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar;8(3):343-57.
doi: 10.2217/nnm.12.124. Epub 2012 Dec 2.

In silico vascular modeling for personalized nanoparticle delivery

Affiliations

In silico vascular modeling for personalized nanoparticle delivery

Shaolie S Hossain et al. Nanomedicine (Lond). 2013 Mar.

Abstract

Aims: To predict the deposition of nanoparticles in a patient-specific arterial tree as a function of the vascular architecture, flow conditions, receptor surface density and nanoparticle properties.

Materials & methods: The patient-specific vascular geometry is reconstructed from computed tomography angiography images. The isogeometric analysis framework integrated with a special boundary condition for the firm wall adhesion of nanoparticles is implemented. A parallel plate flow chamber system is used to validate the computational model in vitro.

Results: Particle adhesion is dramatically affected by changes in patient-specific attributes, such as branching angle and receptor density. The adhesion pattern correlates well with the spatial and temporal distribution of the wall shear rates. For the case considered, the larger (2.0 µm) particles adhere two-times more in the lower branches of the arterial tree, whereas the smaller (0.5 µm) particles deposit more in the upper branches.

Conclusion: Our computational framework in conjunction with patient-specific attributes can be used to rationally select nanoparticle properties to personalize, and thus optimize, therapeutic interventions.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Reconstructing the patient-specific vascular geometry
The image shows, from left to right, the isocontour of a human heart, path extraction and editing of a small bifurcation portion from the left coronary artery (LCA) and reconstruction of the geometry ready for Isogeometric Analysis. Also, a nanoparticle with its ligand molecules is shown interacting with the receptor molecules decorating the surface of the endothelial cells in the vasculature.
Figure 2
Figure 2. Comparison between in silico and in vitro results
The number of adhering particles nadh per unit surface area A normalized by the total number of injected particles ninj is plotted as a function of the particle diameter dp and for three different wall shear rates: (A) S = 10 s-1, (B) S = 75 s-1 and (C) S = 200 s-1. Black crosses with the standard deviation bars represent the experimental results obtained in a parallel plate flow chamber apparatus. The gray areas represent the in silico results obtained for values of the parameters α1 (left) and α2 (right) varying within ± 5% of their average values (α1 = 0.023) and (α2 ≈ 9.44 ×109 #/m2 for dp ≈ 0.7 μm; 1.388×109 #/m2 for dp ≈ 5 μm; and 1.031×109 #/m2 for dp ≈ 7 μm).
Figure 3
Figure 3. Nanoparticle transport in a patient-specific vascular tree
(A) Schematic of the coronary artery (branches identified) with the inlet velocity profile (inset at the right) and applied boundary conditions. (B)-(F) Volumetric concentration C of 0.5 μm nanoparticles, normalized by the concentration at the catheter outlet C0, at various times t post injection: (B) t = 0.2 s, (C) t = 1 s, (D) t = 5 s, (E) t = 10 s, and (F) t = 14 s.
Figure 4
Figure 4. Nanoparticle adhesion to the vessel walls: effect of nanoparticle size
The normalized surface density of adhering nanoparticles is plotted along the arterial tree at various times t post injection, namely (A) t = 5 s, (B) t = 10 s and (C) t = 14 s. The left and right columns present in silico data for the 0.5 and 2.0 μm particle, respectively, in terms of particle number per unit area normalized by the injected dose [cm-2].
Figure 5
Figure 5. Nanoparticle adhesion to the vessel walls: effect of vascular geometry
The normalized surface density of adhering nanoparticles is plotted along the arterial tree at t = 14 s, post injection. The left and right columns present in silico data for the 0.5 and 2.0 μm particles, respectively. The top and bottom rows present in silico data for the smaller (76.8°) and larger (106.8°) branching angles, respectively. Data are presented in particle number per unit area normalized by the injected dose [cm-2].
Figure 6
Figure 6. Nanoparticle adhesion to the vessel walls: effect of surface density of vascular receptors
The normalized surface density of 0.5 μm adhering nanoparticles is plotted along the arterial tree at various times t post injection: (A) t = 1 s, (B) t = 5 s and (C) t = 14 s. Data are presented for a uniform receptor density (mr = 109 #/cm2) along the vasculature (left column) and for a left anterior descending artery receptor density 10 times larger than that in the LCA and LCX (right column). Note that the color map scales are different for the two cases and give the particle number per unit area normalized by the injected dose [cm-2].

References

    1. Weinshilboum R. Genomic medicine - Inheritance and drug response. New England Journal of Medicine. 2003;348(6):529–537. - PubMed
    1. Evans WE, Mcleod HL. Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects. New England Journal of Medicine. 2003;348(6):538–549. - PubMed
    1. Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification. Jama-Journal of the American Medical Association. 2007;298(10):1209–1212. - PubMed
    1. Ghosh S, Matsuoka Y, Asai Y, Hsin KY, Kitano H. Software for systems biology: from tools to integrated platforms. Nat Rev Genet. 2011;12(12):821–832. - PubMed
    1. Vizirianakis IS. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes'. Nanomedicine-Nanotechnology Biology and Medicine. 2011;7(1):11–17. - PubMed

Publication types

LinkOut - more resources